|
|
|
|
| DGA461 | 胆囊癌及匹配的癌旁组织芯片，附病理分级、TNM和临床分期，20例/46点 | | 点 数 | 46 | 例 数 | 20 | | 行 数 | 6 | 列 数 | 8 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
AT (*) Malignant (II) Malignant (IIIA) Malignant (IIIB) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 68 | M | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A2 | 2 | 68 | M | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A3 | 3 | 66 | M | Gallbladder | Papillary adenocarcinoma | 1 | T2N0M0 | II | Malignant | N |
| A4 | 4 | 66 | M | Gallbladder | Papillary adenocarcinoma | 1 | T2N0M0 | II | Malignant | N |
| A5 | 5 | 58 | F | Gallbladder | Adenocarcinoma (sparse) | 1 | T3N0M0 | IIIA | Malignant | N |
| A6 | 6 | 58 | F | Gallbladder | Adenocarcinoma (sparse) | 1 | T3N0M0 | IIIA | Malignant | N |
| A7 | 7 | 55 | M | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A8 | 8 | 55 | M | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B1 | 9 | 74 | F | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B2 | 10 | 74 | F | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B3 | 11 | 40 | F | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B4 | 12 | 40 | F | Gallbladder | Adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B5 | 13 | 66 | M | Gallbladder | Papillary adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B6 | 14 | 66 | M | Gallbladder | Papillary adenocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B7 | 15 | 40 | F | Gallbladder | Adenocarcinoma | 2 | T2N1M0 | IIIB | Malignant | N |
| B8 | 16 | 40 | F | Gallbladder | Adenocarcinoma | 2 | T2N1M0 | IIIB | Malignant | N |
| C1 | 17 | 68 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C2 | 18 | 68 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C3 | 19 | 66 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C4 | 20 | 66 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C5 | 21 | 42 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C6 | 22 | 42 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C7 | 23 | 68 | M | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C8 | 24 | 68 | M | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| D1 | 25 | 65 | F | Gallbladder | Adenocarcinoma | 2 | T2N0M0 | II | Malignant | N |
| D2 | 26 | 65 | F | Gallbladder | Adenocarcinoma | 2 | T2N0M0 | II | Malignant | N |
| D3 | 27 | 71 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| D4 | 28 | 71 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| D5 | 29 | 68 | M | Gallbladder | Adenocarcinoma | 2--3 | T3N0M0 | IIIA | Malignant | N |
| D6 | 30 | 68 | M | Gallbladder | Adenocarcinoma | 2--3 | T3N0M0 | IIIA | Malignant | N |
| D7 | 31 | 68 | F | Gallbladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| D8 | 32 | 68 | F | Gallbladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| E1 | 33 | 74 | F | Gallbladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| E2 | 34 | 74 | F | Gallbladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| E3 | 35 | 60 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| E4 | 36 | 60 | F | Gallbladder | Adenocarcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| E5 | 37 | 64 | F | Gallbladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| E6 | 38 | 64 | F | Gallbladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| E7 | 39 | 66 | M | Gallbladder | Adenocarcinoma | 3 | T2N1M0 | IIIB | Malignant | N |
| E8 | 40 | 66 | M | Gallbladder | Adenocarcinoma | 3 | T2N1M0 | IIIB | Malignant | N |
| F1 | 41 | 68 | M | Gallbladder | Chronic cholecystitis tissue of No.1 | * | * | * | AT | N |
| F2 | 42 | 68 | M | Gallbladder | Chronic cholecystitis tissue of No.2 | * | * | * | AT | N |
| F3 | 43 | 68 | F | Gallbladder | Chronic cholecystitis with epithelial atypical hyperplasia tissue of No.31 | * | * | * | AT | N |
| F4 | 44 | 68 | F | Gallbladder | Chronic cholecystitis tissue of No.32 | * | * | * | AT | N |
| F5 | 45 | 66 | M | Gallbladder | Chronic cholecystitis tissue of No.39 | * | * | * | AT | N |
| F6 | 46 | 66 | M | Gallbladder | Chronic cholecystitis tissue of No.40 | * | * | * | AT | N | | Tissue Marker |
|
|
